&Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$605K Buy
19,227
+5,820
+43% +$183K ﹤0.01% 1594
2025
Q4
$395K Buy
+13,407
New +$372K ﹤0.01% 1754
2024
Q4
Sell
-10,470
Closed -$261K 1671
2024
Q3
$261K Buy
10,470
+2,513
+32% +$74.4K 0.01% 1179
2024
Q2
$236K Buy
+7,957
New +$221K 0.01% 794

Other funds holding RTO

&Partners's RTO Position: Q1 2026 in Review

&Partners increased its Rentokil (RTO) stake by 43% in Q1 2026, buying an estimated $183K and bringing the position to 19,227 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

&Partners first reported a position in RTO in Q2 2024 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • &Partners held 19,227 shares of Rentokil worth $605K as of Q1 2026.
  • &Partners bought 5,820 Rentokil shares in Q1 2026, an estimated $183K.
  • Rentokil made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1594 holding.
  • &Partners first reported a position in Rentokil in Q2 2024 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.